N@N

Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference

^{Published on 2012-11-15 10:01:38 - Market Wire}
 

Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference -- BOULDER, Colo., Nov. 15, 2012 /PRNewswire/ --

[ ]

[ Download image ]

BOULDER, Colo., Nov. 15, 2012 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: [ ARRY ]) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Piper Jaffray Annual Healthcare Conference in New York City.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.  

(Logo: [ http://photos.prnewswire.com/prnh/20121029/LA02195LOGO ]) 

About Array BioPharma

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small‑molecule drugs to treat patients afflicted with cancer. Array is evolving into a late-stage development company, with two wholly‑owned programs, ARRY-614 and ARRY-520, and three partnered programs, selumetinib (with AstraZeneca), MEK162 (with Novartis), and danoprevir (with InterMune / Roche), having the potential to begin Phase 3 or pivotal trials by the end of calendar year 2013.  For more information on Array, please go to [ www.arraybiopharma.com ].

SOURCE Array BioPharma Inc.